|
|
| | (S)-(+)-2,3-Dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione Basic information |
| Product Name: | (S)-(+)-2,3-Dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione | | Synonyms: | PBD-5,11-DIONE;(S)-1,2,3,11A-TETRAHYDRO-10H-PYRROLO[2,1-C][1,4]-BENZODIAZEPINE-5,11-DIONE;(S)-(+)-2,3-dihydro-1H-pyrrolo(2,1C)(1,4)-benzodi;(S)-(+)-2,3-DIHYDRO-1H-PYRROLO(2,1C)(1,4 )-BENZODIAZEPINE-5,11(10H,11AH)DION, 99%;(S)-(+)-2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-;1,2,3,11a-Tetrahydro-10H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-5,11-dione;6a,7,8,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6,11-dione;6a,7,8,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6,11-quinone | | CAS: | 18877-34-4 | | MF: | C12H12N2O2 | | MW: | 216.24 | | EINECS: | | | Product Categories: | Chiral Building Blocks;Heterocyclic Building Blocks;Others | | Mol File: | 18877-34-4.mol | ![(S)-(+)-2,3-Dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione Structure](CAS/GIF/18877-34-4.gif) |
| | (S)-(+)-2,3-Dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione Chemical Properties |
| Melting point | 218-220 °C(lit.) | | Boiling point | 477.4±34.0 °C(Predicted) | | density | 1.35±0.1 g/cm3(Predicted) | | storage temp. | -20°C Freezer | | solubility | DMSO (Slightly, Sonicated), Ethanol (Slightly, Sonicated), Methanol (Slightly) | | form | Solid | | pka | 13.27±0.20(Predicted) | | color | White to Off-White | | Optical Rotation | [α]23/D +525°, c = 0.6 in methanol |
| RIDADR | 2811 | | WGK Germany | 3 | | HazardClass | 6.1(b) | | PackingGroup | III |
| | (S)-(+)-2,3-Dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione Usage And Synthesis |
| Uses | PBD-5,11-dione is a Bnzodiazepines which is used as antileishmanial agents. | | Synthesis Reference(s) | Tetrahedron Letters, 24, p. 5165, 1983 DOI: 10.1016/S0040-4039(00)88387-2 |
| | (S)-(+)-2,3-Dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione Preparation Products And Raw materials |
|